{"id":949796,"date":"2026-04-08T08:05:02","date_gmt":"2026-04-08T12:05:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/"},"modified":"2026-04-08T08:05:02","modified_gmt":"2026-04-08T12:05:02","slug":"collegium-to-participate-in-upcoming-investor-conferences-5","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/","title":{"rendered":"Collegium to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>STOUGHTON, Mass., April  08, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WZ1FnJCqEgn7AHL-O1ow216RIQAxBEAvKz8g3xbNYiSOMjOT99MIK3pHQNp6rG33fgvmzHh9yNOP8YrGx-JHHpoUAbDhhra-VdmBeVKTzMeODgRQYOx1mcUNsO4U_vC5J-N7Yftj7VmR8MAom4LCPEyQ1i6dPXId3T3qrplcSFI2bofNneLqtPZ7OwLVah0lfj-gAPxL6OX99SkxlWbcBv1hR83xrZFvkWX_0_7JNw4hZRlc8yDmjxjKxc61xLp6lEiivvG9Yb73rVWx59wDznBaTYdFY5wDwqHRWs0iW3nOgp0sbOG2guEDMzmtrN0Oh0c4sd97NQHT9PCmK_nWwKIhpin92bqPeGBATPW_QfYFlFf6TT_1qLuwj9WT4OziX943geQs9wt8LjqHvoD7k9_lqcsb4Ky84UjiXWxCu2vql6vsutZRtO7Ah-_LlcSdXiMHA8E6_Y-Vz53h8zCJXkQ3ISh9qwaERz9xJ6FYRA2TevBzS3gEiK3KVMXoUpJZMJiZROwQoA-4zhRaIqJJJQqNbd0MkpoJjj3QDoyvP_9WMymXcRhm10Naks38PB_o\" rel=\"nofollow\" target=\"_blank\">Collegium Pharmaceutical, Inc.<\/a>\u00a0(Nasdaq: COLL) today announced that its management will participate in the following investor conferences:<\/p>\n<p>\n        <strong>25th Annual Needham Virtual Healthcare Conference<\/strong><br \/>\n        <br \/>Fireside Chat Date and Time: Wednesday, April 15, 2026, at 2:15 p.m. ET<br \/>Virtual<\/p>\n<p>A live webcast of the fireside chat will be available via the Investors section of the Company&#8217;s website: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SGCziisFiURfU-ABexktvmpF2nXMUiglWxDsdTYby_rNuOwTQD8Ec3lFNvPoQ477j3k9KcF8DqHqAXIL-zRiFu6XtzKcZdw5d56FQup-mzfMkmpwKa6Tl1EfXTjweJ_T\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.collegiumpharma.com<\/a>. A replay of the webcast will be archived on the Company&#8217;s website for 90 days following the presentation.<\/p>\n<p>\n        <strong>Piper Sandler Spring Biopharma Symposium<\/strong><br \/>\n        <br \/>Thursday, April 16, 2026<br \/>Boston, MA<\/p>\n<p>\n        <strong>About\u00a0Collegium Pharmaceutical, Inc.<\/strong><br \/>\n        <br \/>Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and a rapidly growing neuropsychiatry business driven by Jornay PM\u00ae, a differentiated treatment for ADHD. Collegium\u2019s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium\u2019s headquarters are located in\u00a0Stoughton, Massachusetts. For more information, please visit the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bTxzuvGwrZ6xKUyVAJikQUybl0XKlql9jgMVibyx68Eoyr99_1-ccm66-13XkL4gUHDP7-eEaUvKGTaSAeLrwhJeoovKFzc6lvuxrLqkog5QqqI8i-MmNX2VSiE8TqZdUWtkdgwMuoAxFQ-GpwvpcEUXtEAUWzn2SNs9IrkZwrWamLI1QkO0V_da6CU5KJ732g1chev38rsMwW2FgRBjydw_u1eiYDlyOFvRCVJveMvYxBHkPqphyweJXC1rRUHkqkXcxLGi-Tw_D0CE1pCZXVHGyGBdeLRxBEzeEUaVOic=\" rel=\"nofollow\" target=\"_blank\">www.collegiumpharma.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contacts:<\/strong><br \/>\n        <br \/>Ian Karp<br \/>Head of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2fcqAELsOlrirlU8yOYseENtSucRP_1NUCvr7-k8ot9pyFcuCTqdZ4i032iBkTCHz3pkiohKAxYxhlcwtWXzNhbCO0aZ5kfE8SbMVlw33LCHfomq91lT2Od0XM4nyuPat5xm_GTJlg1E_ohvmlEOclqutD6YqkEFuXCVmau6DsDJKN_YBqo57Dih6t7CO7NRrAGyj0LqW7o3bn_zNdrPz6pkB7C2cG9hk-0boP91wOQURvDVxcjZz27nE2YCOeU0bKezAcVb_sPG3jURgsneTf-RUSJfFTmiSuAb0nhBgl5bGX0B1Aaj5rXZU5c__QTWxs9DanT8v9de0kYKZn4icCO-Q2By6XkVVxn9dOImLTKFY8WdO93NCySfauAo03z7ozmMgq4J09zXFlKixqLiH3B_83ZVuw8OoB0nlVnWCVGyBrismw6l6mvb9E0_dmXT3dZMdXJgprAD8scbI6l9AyqwIXCFqPE9bW9BtYg-4Wl2W0dCy6QAx-8rf0nJOJhf\" rel=\"nofollow\" target=\"_blank\">ir@collegiumpharma.com<\/a><\/p>\n<p>Danielle Jesse<br \/>Director, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2fcqAELsOlrirlU8yOYseENtSucRP_1NUCvr7-k8ot_xUm4PUKJItwDgY4YmIvE3lKhe3sQXrBwkh_jUHJ024nXvl8KizVy3KWDiWqLbXCmBhf4Q0PTqKsLgPA6L_2bcy076Z1qwH_G9mwOFg9lBYNamTeLj_zDv9T30erSNjVA6VSWRZeLek8PieHL4UcRLqbUklvdvhkJs61zC7tJNdNAhbDBUNgnWQbkRBBh5LOi0L7xfb1q57DTiEcJox9ks0ufGxrcxr2iMo8aos0fIqNISc0wuD8-vHgy6rs-NNkA0HnawRgNGbPnSYTT84bfhLZw9xD3yYnBYtpULnTled9A-SmJJLQkDpC6EdzCb7knL7aBEWfargVW555j5LRnzW-q_I_F3k_qJnTc-G3_YdYRITp3udIJOdXp-6pNBGy51xvYuvvLoiKelALPERKjcaw5xMQAQdLiSODvB8EJlC6MjXuYwQ1c4h0Hm9wfBPbbpI0Oe77ILYJ19VVDoWe_8\" rel=\"nofollow\" target=\"_blank\">ir@collegiumpharma.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Jessica Cotrone<br \/>Senior Vice President, Corporate Communications &amp; Corporate Affairs<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rNYh7WC-32mUL40Vg_4cvB_TayqqB4U4bpB6aCcWEL5paCgKxqci-GDv1SL1QalfyWC69XB8GmKKmHYINfzA4Bayze_yUgGPV4JQyzqOXFlb2AwfobOMZxaF3bCJ1LlGdmgvhk2gwcOJ63A0SwGF1iWZ2C0T4HSwrc0whjhKIxc9JCBQJHOUW01CeyCczavK7NZt2Hj19C6ed4wea57FuRuWwaOJ52QlfLtolOFUNpeeLD-LpXALaVHdazoRacjzicv1uV8a4VYhbhnvUIVJT_EWCYErixk0GiT0Wro7I8_h1ASubGeR2BPyV0pNKf9vzqTclnxHYlufMMrZU9NG0FnokQuGNF7bEgoqulcRu4qDkV95zKtdkOfGRTRKV-pWml0fT_vDFDCAh4TN9xASvyyuCoiMqBF0IENdaSn71O2Obcea_-zt2hUa2gTo_xe1wSHsLZjujZudqM3BSIOaTrDO7YvoEickWvXNPYpLiKqe2UmGaPbVc7grlTQK6xQvScGa1hdMJDo6UMI4mcsiIe8vKApx_L6vYzaUnXWOBQlP4ggZgJyVZB60wFaQA_oh6Zl6YIDrwmL8WSaEoGi0Vw==\" rel=\"nofollow\" target=\"_blank\">communications@collegiumpharma.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTU4OCM3NTIzODY2IzIwMTg3MjM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MTJlNTgyNjEtNmI4OC00YzJlLWE0OWItODMxZjY1NjBlOGYyLTEwMzAyOTYtMjAyNi0wNC0wOC1lbg==\/tiny\/Collegium-Pharmaceutical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>STOUGHTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) &#8212; Collegium Pharmaceutical, Inc.\u00a0(Nasdaq: COLL) today announced that its management will participate in the following investor conferences: 25th Annual Needham Virtual Healthcare Conference Fireside Chat Date and Time: Wednesday, April 15, 2026, at 2:15 p.m. ETVirtual A live webcast of the fireside chat will be available via the Investors section of the Company&#8217;s website: https:\/\/ir.collegiumpharma.com. A replay of the webcast will be archived on the Company&#8217;s website for 90 days following the presentation. Piper Sandler Spring Biopharma Symposium Thursday, April 16, 2026Boston, MA About\u00a0Collegium Pharmaceutical, Inc. Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Collegium to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-949796","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Collegium to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Collegium to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"STOUGHTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) &#8212; Collegium Pharmaceutical, Inc.\u00a0(Nasdaq: COLL) today announced that its management will participate in the following investor conferences: 25th Annual Needham Virtual Healthcare Conference Fireside Chat Date and Time: Wednesday, April 15, 2026, at 2:15 p.m. ETVirtual A live webcast of the fireside chat will be available via the Investors section of the Company&#8217;s website: https:\/\/ir.collegiumpharma.com. A replay of the webcast will be archived on the Company&#8217;s website for 90 days following the presentation. Piper Sandler Spring Biopharma Symposium Thursday, April 16, 2026Boston, MA About\u00a0Collegium Pharmaceutical, Inc. Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of &hellip; Continue reading &quot;Collegium to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-08T12:05:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTU4OCM3NTIzODY2IzIwMTg3MjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-participate-in-upcoming-investor-conferences-5\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-participate-in-upcoming-investor-conferences-5\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Collegium to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-04-08T12:05:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-participate-in-upcoming-investor-conferences-5\\\/\"},\"wordCount\":220,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-participate-in-upcoming-investor-conferences-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTU4OCM3NTIzODY2IzIwMTg3MjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-participate-in-upcoming-investor-conferences-5\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-participate-in-upcoming-investor-conferences-5\\\/\",\"name\":\"Collegium to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-participate-in-upcoming-investor-conferences-5\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-participate-in-upcoming-investor-conferences-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTU4OCM3NTIzODY2IzIwMTg3MjM=\",\"datePublished\":\"2026-04-08T12:05:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-participate-in-upcoming-investor-conferences-5\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-participate-in-upcoming-investor-conferences-5\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-participate-in-upcoming-investor-conferences-5\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTU4OCM3NTIzODY2IzIwMTg3MjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NTU4OCM3NTIzODY2IzIwMTg3MjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-participate-in-upcoming-investor-conferences-5\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Collegium to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Collegium to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/","og_locale":"en_US","og_type":"article","og_title":"Collegium to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"STOUGHTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) &#8212; Collegium Pharmaceutical, Inc.\u00a0(Nasdaq: COLL) today announced that its management will participate in the following investor conferences: 25th Annual Needham Virtual Healthcare Conference Fireside Chat Date and Time: Wednesday, April 15, 2026, at 2:15 p.m. ETVirtual A live webcast of the fireside chat will be available via the Investors section of the Company&#8217;s website: https:\/\/ir.collegiumpharma.com. A replay of the webcast will be archived on the Company&#8217;s website for 90 days following the presentation. Piper Sandler Spring Biopharma Symposium Thursday, April 16, 2026Boston, MA About\u00a0Collegium Pharmaceutical, Inc. Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of &hellip; Continue reading \"Collegium to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-08T12:05:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTU4OCM3NTIzODY2IzIwMTg3MjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Collegium to Participate in Upcoming Investor Conferences","datePublished":"2026-04-08T12:05:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/"},"wordCount":220,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTU4OCM3NTIzODY2IzIwMTg3MjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/","name":"Collegium to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTU4OCM3NTIzODY2IzIwMTg3MjM=","datePublished":"2026-04-08T12:05:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTU4OCM3NTIzODY2IzIwMTg3MjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NTU4OCM3NTIzODY2IzIwMTg3MjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-participate-in-upcoming-investor-conferences-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Collegium to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=949796"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/949796\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=949796"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=949796"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=949796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}